迈得医疗(688310) - 2021 Q3 - 季度财报

Revenue and Profit - Revenue for Q3 2021 reached ¥64,290,077.42, an increase of 28.69% compared to the same period last year[4] - Net profit attributable to shareholders was ¥15,558,095.61, up 49.92% year-on-year[4] - Net profit excluding non-recurring gains and losses was ¥14,032,644.40, a 42.77% increase from the previous year[4] - Basic earnings per share for the period was ¥0.19, reflecting a 58.33% increase compared to the same period last year[5] - Total operating revenue for the first three quarters of 2021 reached ¥193,295,941.21, an increase of 17.7% compared to ¥164,290,395.12 in the same period of 2020[21] - Net profit for the first three quarters of 2021 was ¥38,823,970.51, a decrease of 24.4% from ¥51,310,892.84 in the same period of 2020[22] - Earnings per share for the first three quarters of 2021 were ¥0.47, down from ¥0.62 in the previous year[23] Research and Development - Total R&D investment amounted to ¥9,409,684.39, representing a 44.77% increase year-on-year[5] - R&D expenses accounted for 14.64% of revenue, an increase of 1.63 percentage points compared to the previous year[5] - Research and development expenses for the first three quarters of 2021 amounted to ¥22,330,472.31, an increase from ¥19,541,128.25 in the previous year[21] Cash Flow and Assets - Cash flow from operating activities for the year-to-date was ¥21,922,778.27, down 51.36% compared to the previous year[4] - The company's cash and cash equivalents decreased from 425,461,900.65 RMB at the end of 2020 to 330,348,840.49 RMB by September 30, 2021, a decline of approximately 22.3%[15] - Total current assets amounted to 601,404,589.70 RMB, down from 664,895,499.16 RMB year-over-year[17] - Non-current assets increased from 151,117,287.16 RMB to 214,829,498.76 RMB, reflecting a growth of approximately 42%[17] - The total assets of the company were reported at 816,234,088.46 RMB, slightly up from 816,012,786.32 RMB at the end of 2020[17] - The total liabilities as of the end of the third quarter of 2021 were ¥83,171,755.42, compared to ¥80,289,985.84 at the end of the previous year[18] - Total equity attributable to shareholders was ¥734,752,080.43, slightly down from ¥736,960,222.79 in the previous year[18] Shareholder Information - The total number of common shareholders at the end of the reporting period was 2,748[11] - The top shareholder, Lin Junhua, holds 39,986,000 shares, representing 47.83% of total shares[11] Inventory and Costs - The company reported a significant increase in inventory from 101,936,175.45 RMB to 121,988,401.13 RMB, indicating a rise of approximately 19.6%[15] - Total operating costs for the first three quarters of 2021 were ¥164,318,501.66, up 45.1% from ¥113,068,088.95 in the previous year[21] Financial Activities - The company plans to implement a stock incentive plan as approved in the board meetings held in September and October 2021[13] - The company has engaged in strategic placements, with Guangfa Qianhe Investment Co., Ltd. participating in the IPO with a subscription of 1,045,000 shares, accounting for 5% of the total issuance[12] - The company reported a financial income of ¥3,614,170.86 for the first three quarters of 2021, compared to ¥7,615,187.03 in the same period of 2020[21] Cash Flow from Activities - The net cash flow from operating activities was $21,922,778.27, a decrease of 51.2% compared to $45,067,757.03 in the previous year[26] - Total cash outflow from operating activities amounted to $184,058,633.84, up from $173,070,312.10 year-over-year[26] - The net cash flow from investing activities was -$74,003,278.82, compared to $325,008,603.52 in the same period last year, indicating a significant decline[26] - The net cash flow from financing activities was -$42,811,848.24, compared to -$58,089,505.67 in the previous year, showing an improvement[27] - The total cash and cash equivalents at the end of the period were $330,348,840.49, down from $423,656,014.66 year-over-year[27] - The company paid $41,800,000.00 in dividends and interest, an increase from $29,439,505.67 in the previous year[27] - The cash outflow from financing activities was $42,811,848.24, compared to $58,089,505.67 in the same period last year[27] - The impact of exchange rate changes on cash and cash equivalents was -$220,711.37, contrasting with a positive impact of $16,273.89 in the previous year[27] - The company reported a significant increase in cash outflow related to employee payments, totaling $58,675,709.68, compared to $43,397,854.19 last year[26] Margin and Product Mix - The company experienced a decline in gross margin due to a shift in product mix, with lower margins from customized products compared to last year's higher-margin products[9]